Ensign Peak Advisors’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.2M | Buy |
|
|||||
|
2025
Q1 | $15.8M | Sell |
|
|||||
|
2024
Q4 | $20.5M | Sell |
|
|||||
|
2024
Q3 | $46.7M | Buy |
|
|||||
|
2024
Q2 | $23.1M | Sell |
|
|||||
|
2024
Q1 | $24.2M | Hold |
|
|||||
|
2023
Q4 | $20.8M | Buy |
|
|||||
|
2023
Q3 | $18M | Sell |
|
|||||
|
2023
Q2 | $25.2M | Sell |
|
|||||
|
2023
Q1 | $12.6M | Hold |
|
|||||
|
2022
Q4 | $19.8M | Hold |
|
|||||
|
2022
Q3 | $19.5M | Buy |
|
|||||
|
2022
Q2 | $14.1M | Buy |
|
|||||
|
2022
Q1 | $15M | Sell |
|
|||||
|
2021
Q4 | $25.9M | Buy |
|
|||||
|
2021
Q3 | $37.6M | Sell |
|
|||||
|
2021
Q2 | $41.3M | Sell |
|
|||||
|
2021
Q1 | $46.6M | Buy |
|
|||||
|
2020
Q4 | $40.7M | Buy |
|
|||||
|
2020
Q3 | $32.7M | Buy |
|
|||||
|
2020
Q2 | $28M | Buy |
|
|||||
|
2020
Q1 | $15.4M | Sell |
|
|||||
|
2019
Q4 | $19.2M | Buy |
|